SG11201510028PA - Carbazole carboxamide compounds useful as kinase inhibitors - Google Patents
Carbazole carboxamide compounds useful as kinase inhibitorsInfo
- Publication number
- SG11201510028PA SG11201510028PA SG11201510028PA SG11201510028PA SG11201510028PA SG 11201510028P A SG11201510028P A SG 11201510028PA SG 11201510028P A SG11201510028P A SG 11201510028PA SG 11201510028P A SG11201510028P A SG 11201510028PA SG 11201510028P A SG11201510028P A SG 11201510028PA
- Authority
- SG
- Singapore
- Prior art keywords
- kinase inhibitors
- compounds useful
- carboxamide compounds
- carbazole carboxamide
- carbazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361839130P | 2013-06-25 | 2013-06-25 | |
| PCT/US2014/043980 WO2014210087A1 (en) | 2013-06-25 | 2014-06-25 | Carbazole carboxamide compounds useful as kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201510028PA true SG11201510028PA (en) | 2016-01-28 |
Family
ID=51210832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510028PA SG11201510028PA (en) | 2013-06-25 | 2014-06-25 | Carbazole carboxamide compounds useful as kinase inhibitors |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9714234B2 (en) |
| EP (1) | EP3013815B1 (en) |
| JP (1) | JP6353530B2 (en) |
| KR (1) | KR102345381B1 (en) |
| CN (1) | CN105473573B (en) |
| AU (1) | AU2014302550A1 (en) |
| BR (1) | BR112015031432A2 (en) |
| CA (1) | CA2916504A1 (en) |
| EA (1) | EA025863B1 (en) |
| IL (1) | IL243295A0 (en) |
| MX (1) | MX2015016771A (en) |
| SG (1) | SG11201510028PA (en) |
| WO (1) | WO2014210087A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015335783B2 (en) | 2014-10-24 | 2019-10-03 | Bristol-Myers Squibb Company | Tricyclic atropisomer compounds |
| SI3461821T1 (en) | 2014-10-24 | 2020-09-30 | Bristol-Myers Squibb Company | Indole carboxamide compounds useful as kinase inhibitors |
| TN2017000158A1 (en) | 2014-10-24 | 2018-10-19 | Bristol Myers Squibb Co | Carbazole derivatives |
| CN105802100A (en) * | 2016-04-22 | 2016-07-27 | 宁波硫华聚合物有限公司 | Rubber accelerator bonding agent hexakis(methoxymethyl)melamine pre-dispersed rubber master batch particle and preparation method thereof |
| CN105694150A (en) * | 2016-04-25 | 2016-06-22 | 无锡智谷锐拓技术服务有限公司 | Oil-resistant rubber |
| CN105670057A (en) * | 2016-04-25 | 2016-06-15 | 无锡智谷锐拓技术服务有限公司 | Preparation method of oil resistant rubber |
| CN106084903A (en) * | 2016-06-02 | 2016-11-09 | 扬州兰都塑料科技有限公司 | A kind of preparation method of the aqueous fire-proof coating of Exterior cable coating |
| CN105907150A (en) * | 2016-06-02 | 2016-08-31 | 扬州兰都塑料科技有限公司 | Fire retardant for cable coating |
| CN106045972B (en) * | 2016-06-03 | 2018-11-16 | 中山大学 | Carbazole-rivastigmine dyad and its pharmaceutical composition and application |
| WO2022140246A1 (en) | 2020-12-21 | 2022-06-30 | Hangzhou Jijing Pharmaceutical Technology Limited | Methods and compounds for targeted autophagy |
| CN115232061B (en) * | 2021-09-18 | 2024-01-30 | 山西紫罗蓝新材料科技有限公司 | Extraction process of 3-nitro-9-ethylcarbazole crude product |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200750A (en) | 1977-01-07 | 1980-04-29 | Westwood Pharmaceuticals Inc. | 4-Substituted imidazo [1,2-a]quinoxalines |
| CA2140722A1 (en) | 1994-01-24 | 1995-07-25 | Joseph A. Jakubowski | Beta-carboline thromboxane synthase inhibitors |
| WO2005014599A1 (en) | 2003-06-04 | 2005-02-17 | Cellular Genomics, Inc. | Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds |
| US7393848B2 (en) | 2003-06-30 | 2008-07-01 | Cgi Pharmaceuticals, Inc. | Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds |
| WO2005047290A2 (en) | 2003-11-11 | 2005-05-26 | Cellular Genomics Inc. | Imidazo[1,2-a] pyrazin-8-ylamines as kinase inhibitors |
| EP1812439B2 (en) | 2004-10-15 | 2017-12-06 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| KR20070119606A (en) | 2004-11-10 | 2007-12-20 | 씨지아이 파마슈티칼스, 인크. | Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof |
| PL1831227T3 (en) | 2004-12-17 | 2013-10-31 | Glenmark Pharmaceuticals Sa | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| EP1863766B1 (en) | 2005-03-10 | 2015-05-20 | Gilead Connecticut, Inc. | Certain substituted amides, method of making, and method of use thereof |
| US20070078136A1 (en) | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| US7723336B2 (en) | 2005-09-22 | 2010-05-25 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| JP5249772B2 (en) | 2005-11-22 | 2013-07-31 | メルク・シャープ・アンド・ドーム・コーポレーション | Tricyclic compounds useful as inhibitors of kinases |
| SG174810A1 (en) | 2006-09-11 | 2011-10-28 | Matrix Lab Ltd | Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| WO2008033858A2 (en) | 2006-09-11 | 2008-03-20 | Cgi Pharmaceuticals, Inc. | Kinase inhibitors, and methods of using and identifying kinase inhibitors |
| US20090062251A1 (en) | 2007-08-17 | 2009-03-05 | Astrazeneca Ab | Novel Compounds 002 |
| WO2009075830A1 (en) | 2007-12-13 | 2009-06-18 | Merck & Co., Inc. | Inhibitors of janus kinases |
| EP2247558B2 (en) | 2008-02-14 | 2024-07-03 | Eli Lilly and Company | Novel imaging agents for detecting neurological dysfunction |
| GB0809360D0 (en) | 2008-05-22 | 2008-07-02 | Isis Innovation | Calcium modulation |
| EP2307418B1 (en) * | 2008-07-18 | 2014-03-12 | F.Hoffmann-La Roche Ag | Novel phenylimidazopyrazines |
| EP2151441A1 (en) | 2008-08-06 | 2010-02-10 | Julius-Maximilians-Universität Würzburg | Beta-carbolin-derivates as substrates for an enzyme |
| CA2747670A1 (en) | 2008-12-19 | 2010-07-15 | Bristol-Myers Squibb Company | Carbazole carboxamide compounds useful as kinase inhibitors |
| CN101475571B (en) | 2009-01-21 | 2011-06-22 | 中国药科大学 | Beta-carbolines cell cycle protein related kinase 2 inhibitor and use thereof |
| US8242260B2 (en) | 2009-08-28 | 2012-08-14 | Novartis Ag | Compounds and compositions as protein kinase inhibitors |
| WO2011159857A1 (en) * | 2010-06-16 | 2011-12-22 | Bristol-Myers Squibb Company | Carboline carboxamide compounds useful as kinase inhibitors |
| EP2455378A1 (en) | 2010-11-03 | 2012-05-23 | Philip Morris Products S.A. | Carbazole and carboline derivatives, and preparation and therapeutic applications thereof |
| WO2012066442A1 (en) | 2010-11-15 | 2012-05-24 | Pfizer Limited | Inhibitors of hiv replication |
| AU2012257802A1 (en) | 2011-05-17 | 2013-10-31 | F. Hoffmann-La Roche Ag | Inhibitors of Bruton's tyrosine kinase |
| TWI648272B (en) | 2013-06-25 | 2019-01-21 | 美商必治妥美雅史谷比公司 | Substituted tetrahydrocarbazole and carbazole carbamide compounds |
-
2014
- 2014-06-25 CN CN201480046669.2A patent/CN105473573B/en not_active Expired - Fee Related
- 2014-06-25 MX MX2015016771A patent/MX2015016771A/en unknown
- 2014-06-25 CA CA2916504A patent/CA2916504A1/en not_active Abandoned
- 2014-06-25 JP JP2016523870A patent/JP6353530B2/en not_active Expired - Fee Related
- 2014-06-25 EA EA201690012A patent/EA025863B1/en not_active IP Right Cessation
- 2014-06-25 EP EP14740096.4A patent/EP3013815B1/en not_active Not-in-force
- 2014-06-25 AU AU2014302550A patent/AU2014302550A1/en not_active Abandoned
- 2014-06-25 BR BR112015031432A patent/BR112015031432A2/en not_active Application Discontinuation
- 2014-06-25 KR KR1020167001634A patent/KR102345381B1/en active IP Right Grant
- 2014-06-25 SG SG11201510028PA patent/SG11201510028PA/en unknown
- 2014-06-25 WO PCT/US2014/043980 patent/WO2014210087A1/en active Application Filing
- 2014-06-25 US US14/392,355 patent/US9714234B2/en active Active
-
2015
- 2015-12-22 IL IL243295A patent/IL243295A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6353530B2 (en) | 2018-07-04 |
| EA025863B1 (en) | 2017-02-28 |
| EP3013815B1 (en) | 2017-05-03 |
| JP2016523908A (en) | 2016-08-12 |
| KR102345381B1 (en) | 2021-12-29 |
| US9714234B2 (en) | 2017-07-25 |
| EA201690012A1 (en) | 2016-05-31 |
| AU2014302550A1 (en) | 2016-02-11 |
| WO2014210087A1 (en) | 2014-12-31 |
| KR20160022890A (en) | 2016-03-02 |
| MX2015016771A (en) | 2016-03-31 |
| EP3013815A1 (en) | 2016-05-04 |
| BR112015031432A2 (en) | 2017-07-25 |
| CN105473573B (en) | 2018-03-16 |
| IL243295A0 (en) | 2016-02-29 |
| CA2916504A1 (en) | 2014-12-31 |
| US20160200710A1 (en) | 2016-07-14 |
| CN105473573A (en) | 2016-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME03740B (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| HK1253099A1 (en) | Heterocyclic amides as kinase inhibitors | |
| IL244224A0 (en) | Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors | |
| AP2015008632A0 (en) | Biaryl amide compounds as kinase inhibitors | |
| HK1211578A1 (en) | Amidoimidazopyridazines as mknk-1 kinase inhibitors mknk-1 | |
| HK1223359A1 (en) | Substituted tetrahydrocarbazole and carbazole carboxamide compounds useful as kinase inhibitors | |
| IL243295A0 (en) | Carbazole carboxamide compounds useful as kinase inhibitors | |
| HK1217654A1 (en) | Furanone compounds as kinase inhibitors |